Identification of Pregnancy Adverse Drug Reactions in Pharmacovigilance Reporting Systems: A Novel Algorithm Developed in EudraVigilanceDRUG SAFETYIF3.82024-06-191OAAI
Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass VaccinationDRUG SAFETYIF3.82024-04-093OAAI
Predicting the submission frequency of periodic safety update reports: development and application of the EURD toolFRONTIERS IN MEDICINEIF32024-02-080OAAI
Safety Monitoring of COVID-19 Vaccines: Perspective from the European Medicines AgencyCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52023-02-0621OAAI
The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse ReactionsDRUG SAFETYIF3.82021-12-0812OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向